Navigation Links
Getting aid to where it is needed
Date:7/3/2011

In the early 2000s, the international aid community started to fund health programs through Global Health Initiatives (GHIs) which provide aid and support for tackling infectious diseases, and for implementing immunization programs against childhood diseases. However priorities set by GHIs and by governments are not always the same. New research published in BioMed Central's open access journal Globalization and Health uses 'agency theory' to examine the conflicts between donor and recipient countries.

In order to find out how GHIs have been operating, researchers from the London School of Hygiene &Tropical Medicine and Queen Margaret University, Edinburgh undertook detailed interviews with policy makers and officials from GHIs, and with the Ugandan government. They also examined both published and unpublished documentation, and observed policy meetings regarding the allocation of GHIs funds.

Using agency theory, designed to look at the conflict between two sets of people with interest in the same assets, such as shareholders and company managers, the results from Uganda show a strong conflict of interest between the priorities set by the GHIs, such as The President's Emergency Plan for AIDS Relief in Africa (PEPFAR) and the Global Fund, which tackles HIV/AIDS, tuberculosis and malaria, and those of the government. It seemed that while the GHIs approach was good at providing short-term aid, the government would have preferred to have resources allocated in a more flexible manner, allowing them to use the additional contributions as part of their general (or health) budgets, investing in long term benefits.

Dr Oliveira-Cruz said, "The problem is that often the aid bureaucracy is too complex. Each organization is made up of different individuals, who each have their own motivations, resulting in conflicting priorities being pursued by the GHIs and the government. While funds provided by GHIs are alleviating the suffering of ma
'/>"/>

Contact: Dr. Hilary Glover
hilary.glover@biomedcentral.com
44-203-192-2370
BioMed Central
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Getting an accurate read on Parkinsons
2. Women May Be Getting Unneeded Heart Imaging Tests
3. High-Risk Surgeries Getting Safer: Study
4. Too Many Kids Getting Antibiotics for Asthma
5. Breast Shield Better for Women Getting Chest CT Scan: Study
6. Getting a grasp on memory
7. Getting healthy: When does prediction help people change their habits?
8. Study looks at getting stroke patients back on their feet
9. Getting to the scientific heart of what makes romantic relationships succeed or fail
10. Getting more anti-cancer medicine into the blood
11. Survey Shows Fewer Hispanic Seniors Getting Flu Shots
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... Westlake Village, CA (PRWEB) September 23, 2014 ... Sedation Dental Office is now offering complimentary oral sedation ... about 15 percent of Americans suffer from dental anxiety ... merely uncomfortable for patients; they can also keep patients ... dental anxiety or phobia in Westlake Village and surrounding ...
(Date:9/23/2014)... September 23, 2014 PM360, a leading ... the pharmaceutical industry with their annual Trailblazer Awards on ... gala banquet at Gotham Hall in New York City, ... representing top talent and brands. , ... says Anna Stashower, CEO and Publisher of PM360. “We ...
(Date:9/23/2014)... 23, 2014 Kenall Manufacturing, a ... its MedMaster™ M4 product line with a new ... M4 product line – currently available with 2'×2' ... providing more flexibility when designing lighting for the ... M4 Series include:, •Three sizes available to ...
(Date:9/23/2014)... Rockville, MD (PRWEB) September 23, 2014 ... a proposal by the World Health Organization (WHO) regarding ... , USP supports the effort by the Expert Group ... develop a consensus-based global approach to the naming of ... principles critical to the quality assessment of these drugs. ...
(Date:9/23/2014)... 2014 Catalent Pharma Solutions, ... technologies and development solutions for drugs, biologics ... it had reached an exclusive development and ... Cingulate Therapeutics (CTx), to support the development ... products for the treatment of Attention Deficit/Hyperactivity ...
Breaking Medicine News(10 mins):Health News:The Sedation Dental Office is Now Offering Complimentary Oral Sedation with Treatment for New Patients 2Health News:The Sedation Dental Office is Now Offering Complimentary Oral Sedation with Treatment for New Patients 3Health News:PM360 Magazine Announces Winners of 2014 Trailblazer Awards 2Health News:PM360 Magazine Announces Winners of 2014 Trailblazer Awards 3Health News:PM360 Magazine Announces Winners of 2014 Trailblazer Awards 4Health News:PM360 Magazine Announces Winners of 2014 Trailblazer Awards 5Health News:PM360 Magazine Announces Winners of 2014 Trailblazer Awards 6Health News:Kenall Expands MedMaster™ M4 Surgical Suite Product Portfolio with New 1'×4' Option 2Health News:Kenall Expands MedMaster™ M4 Surgical Suite Product Portfolio with New 1'×4' Option 3Health News:USP Comments to WHO Regarding Biologics Qualifier Proposal 2Health News:Catalent and Cingulate Therapeutics Sign Exclusive Agreement for Development of New ADHD Treatments 2Health News:Catalent and Cingulate Therapeutics Sign Exclusive Agreement for Development of New ADHD Treatments 3
... HOUSTON - A $4 million, five-year grant from the ... Networks Program Center (CNPC), called Latinos Contra El Cancer, ... The center is a joint project of The ... School of Public Health and The University of Texas ...
... low-dose radiation from cardiac imaging and other procedures after ... of cancer, found a new study published in ... link only) http://www.cmaj.ca/embargo/cmaj100463.pdf . The use of ... (CT) angiography and nuclear scans, is increasing which has ...
... of Sweden decided to introduce a special blessing for ... making a distinction between genuine homosexuality and promiscuous homosexuality, ... a new thesis in religious studies at the University ... between opponents and supporters of the decision. "It ...
... rates continue to rise, University of Missouri researchers are ... an effective and inexpensive way for people with addictive ... Matthew Martens, associate professor of Educational, School and Counseling ... team of researchers received a $172,500 grant from ...
... produced by the DNA of tumor cells, researchers have ... new treatment for the often-fatal childhood cancer neuroblastoma. Oncologists ... of a drug that blocks the protein,s activity. ... target for high-risk neuroblastoma," said pediatric oncologist Kristina A. ...
... two new works, an anthropologist tackles a perplexing question relating ... tolerate and even celebrate the public display of ... of Real Human Bodies " is the most widely attended ... professor of anthropology at the University of Illinois and author ...
Cached Medicine News:Health News:Project connects researchers, Latino communities to prevent cancer 2Health News:Project connects researchers, Latino communities to prevent cancer 3Health News:Risk of cancer increases with exposure to low-dose radiation 2Health News:Supporters and opponents of a special blessing for homosexuals share many values 2Health News:Simple feedback could be effective therapy for addictive behaviors 2Health News:Protein may be key to new treatment in a childhood cancer 2Health News:Protein may be key to new treatment in a childhood cancer 3Health News:Anthropologist: 'Body Worlds' visitors confront bodies but not death 2Health News:Anthropologist: 'Body Worlds' visitors confront bodies but not death 3
(Date:9/23/2014)... , Sept. 23, 2014 Today, DripDrop, the ... the formation of the DripDrop Foundation, with its ... dehydration worldwide. Utilizing scientific advancements in Oral Rehydration ... to reduce dehydration and healthcare costs through strategic ... "DripDrop has been used in ...
(Date:9/23/2014)... , Sept. 23, 2014   BioLife Solutions ... developer, manufacturer and marketer of proprietary clinical grade ... and precision thermal shipping products for cells ... new additions to its Scientific Advisory Board.  The new ... Anthony Davies , PhD. Dr. Acker is ...
(Date:9/22/2014)... BARCELONA , España, September 23, 2014 ... nube permite que los patrocinadores de ensayos clínicos satisfagan ... a la accesibilidad y exhaustividad de los expedientes permanentes ... La mayor encuesta sobre TMF en el ... un aumento en el número de patrocinadores de ensayos ...
Breaking Medicine Technology:DripDrop Forms Foundation To Scale Relief Efforts 2BioLife Solutions Announces the Addition of Jason Acker, MBA, PhD and Anthony Davies, PhD to its Scientific Advisory Board 2BioLife Solutions Announces the Addition of Jason Acker, MBA, PhD and Anthony Davies, PhD to its Scientific Advisory Board 3BioLife Solutions Announces the Addition of Jason Acker, MBA, PhD and Anthony Davies, PhD to its Scientific Advisory Board 4BioLife Solutions Announces the Addition of Jason Acker, MBA, PhD and Anthony Davies, PhD to its Scientific Advisory Board 5BioLife Solutions Announces the Addition of Jason Acker, MBA, PhD and Anthony Davies, PhD to its Scientific Advisory Board 6BioLife Solutions Announces the Addition of Jason Acker, MBA, PhD and Anthony Davies, PhD to its Scientific Advisory Board 7El acceso remoto al eTMF se duplicará en 2015, revela una encuesta general del sector 2El acceso remoto al eTMF se duplicará en 2015, revela una encuesta general del sector 3El acceso remoto al eTMF se duplicará en 2015, revela una encuesta general del sector 4El acceso remoto al eTMF se duplicará en 2015, revela una encuesta general del sector 5
... Adeona Pharmaceuticals, Inc. (AMEX: ... for serious central nervous system diseases, announced today ... the randomized, double-blind, placebo-controlled, multi-center clinical trial of ... multiple sclerosis (MS) in women, per the original ...
... MARLBOROUGH, Mass., Sept. 19, 2011 Advanced Cell Technology, ... of regenerative medicine, announced today that it has been ... the Company,s proprietary method for generating and expanding hemangioblast ... an exclusive license to commercialize the patented technology in ...
Cached Medicine Technology:Adeona Announces Completion of Planned Enrollment in Phase II Multiple Sclerosis Clinical Trial 2Adeona Announces Completion of Planned Enrollment in Phase II Multiple Sclerosis Clinical Trial 3Adeona Announces Completion of Planned Enrollment in Phase II Multiple Sclerosis Clinical Trial 4Adeona Announces Completion of Planned Enrollment in Phase II Multiple Sclerosis Clinical Trial 5ACT Secures First Patent for Generating Hemangioblast Cells to Treat a Broad Spectrum of Vascular and Hematopoietic Disorders 2ACT Secures First Patent for Generating Hemangioblast Cells to Treat a Broad Spectrum of Vascular and Hematopoietic Disorders 3ACT Secures First Patent for Generating Hemangioblast Cells to Treat a Broad Spectrum of Vascular and Hematopoietic Disorders 4
The Atria 6100 delivers the highest level of clinical performance while incorporating cutting-edge technology to streamline clinic workflow. It offers timely, high-quality, and accurate ECG results c...
The CSV-1000ETDRS10% test face presents the standard ETDRS test at a contrast level of 10%. This test is widely used in clinical studies for the evaluation of refractive surgery and contact lenses....
The CSV-1000SLanC test face provides the same tests as the standard CSV-1000S, except that the acuity test is presented in Landolt C format. , ,This test is very useful when testing patients who cann...
... face is the most widely used contrast sensitivity ... four (4) rows of sine-wave gratings. At the ... these gratings test the spatial frequencies of 3, ... a full contrast sensitivity curve, which is very ...
Medicine Products: